Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LaSara Medical Group vs Oria Meds

By GLP-1 ScorecardUpdated

LaSara Medical GroupFactor scores not reassessed.
Site position #486

Lower score

Oria MedsFactor scores not reassessed.
Site position #272

Higher score

Score comparison

Oria Meds has the higher recorded score — 63.6/100 to 54.5/100.

Oria Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oria Meds' first-month prices give way to standing rates of $299 a month for semaglutide and $399 for tirzepatide.

Before you choose

Before comparing the headline prices, the LaSara Medical Group review and the Oria Meds review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, LaSara Medical Group vs Tryozi and Mint Medical Clinic vs Oria Meds compare each of them with another graded program, and the list of alternatives to LaSara Medical Group ranks the programs closest to LaSara Medical Group on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HumeCare+ review covers one graded close to these two, at 58.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueOria Meds +21
33
54
Dose & formulationEven
64
64
Clinical oversightLaSara Medical Group +4
69
65
Labs & monitoringLaSara Medical Group +1
53
52
FulfillmentOria Meds +27
66
93
Contract termsOria Meds +20
47
67
LaSara Medical Group · top barOria Meds · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricLaSara Medical GroupOria Meds
WeighScore54.5/10063.6/100
GradeCC
Site position#486#272
Semaglutide$289/mo (compounded)$179 first month, then $299/mo ($249/mo renewal on 3-month plan; compounded)
Tirzepatide$399/mo (bundle, compounded)$279 first month, then $399/mo ($356/mo renewal on 3-month plan; compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
LaSara Medical Group

Site position #486 · C

Factor scores not reassessed.

Strengths

  • Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, and enclomiphene
  • National telehealth plus an in-person option in Southern California — uncommon hybrid model
  • Free initial consultation
  • Active promotional pricing (30% off sitewide at the time of review)
  • GLP-1 pricing now published on product pages: compounded semaglutide from $233/mo, tirzepatide from $325/mo on annual bundles

What to consider

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy partner not named
  • LegitScript certification status not confirmed
  • Per-state availability not listed despite the national-telehealth claim
  • Lab work and ongoing monitoring inclusion not clearly disclosed for the multi-modality menu
Oria Meds

Site position #272 · C

Factor scores not reassessed.

Strengths

  • Names its dispensing pharmacy, PerfectRx, with a street address and a phone number
  • Free shipping and interest-free installments are offered at checkout
  • The intake's plan menu returned identical ladders in two different states, so the price is not being varied by geography in the states tested
  • Coverage is stated as all 50 states, subject to provider availability

What to consider

  • The homepage sells “starting at $149” and “starting at $249” and neither figure appears in the intake in either state tested
  • Standing rates rose: semaglutide is $299 a month after a $179 first month (October: $199), and tirzepatide $399 after $279 (October: $369)
  • A second price table sits in the homepage script and renders nowhere, quoting a $329 tirzepatide figure the live intake contradicts
  • Two different scarcity counters appear on consecutive checkout screens, and review turnaround is stated as 24 hours in one place and 48 in another
  • No legal entity, state of organization or governing law is published, and no clinician or NPI is named

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard